Endoscopic submucosal dissection (ESD) is advocated as a superior treatment approach for large laterally spreading colorectal lesions (LSL). Its key advantage over e-field endoscopic mucosal resection (WF-EMR) pertains to en bloc resection and potential cure of low risk submucosal invasive cancer. ESD has a steep learning curve, high cost and greater risk of signficant adverse events. The applicability and cost implications of colorectal ESD is yet to be determined.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Gastrointestinal Endoscopy
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2017 Published by Elsevier Inc.